title: Clinical translational science 2020: disruptive innovation redefines the discovery-application enterprise.
authors.affiliation: Department of Pharmacology and Experimental Therapeutics, Division of Clinical Pharmacology, Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USA. scott.waldman@jefferson.edu
authors.forename: Scott A
authors.initials: SA
authors.lastname: Waldman
authors.forename: Andre
authors.initials: A
authors.lastname: Terzic
mesh_terms: D055808:Drug Discovery / Q000331:legislation & jurisprudence; D009316:National Institutes of Health (U.S.); D009936:Organizational Innovation; D057170:Translational Research, Biomedical / Q000331:legislation & jurisprudence / Q000458:organization & administration*; D014481:United States